1.
Gangat N, Bellam N, Reichard K, Tefferi A. Emergence of <i>TP53</i&gt; mutation during lenalidomide therapy of myelodysplastic syndrome with del(5q) and its subsequent disappearance following salvage therapy with decitabine. haematol [Internet]. 2024Mar.31 [cited 2024Apr.12];109(4):1306-9. Available from: https://haematologica.org/article/view/haematol.2023.284547